Finance

Lists
000403:SHE
Pacific Shuanglin Bio-pharmacy Co Ltd
9,50 CN¥
-0,63%
(-0,060) 1D
16 қаз., 15:04:24 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000403...
Open
9,62 CN¥
High
9,79 CN¥
Low
9,36 CN¥
Mkt. cap
9,22 млрд
Avg. vol.
5,57 млн
Volume
6,30 млн
P/E ratio
33,80
52-wk high
16,58 CN¥
52-wk low
8,54 CN¥
EPS
0,28 CN¥
Shares outstanding
950,40 млн
No. of employees
3 мың
Open
9,62 CN¥
High
9,79 CN¥
Low
9,36 CN¥
Mkt. cap
9,22 млрд
Avg. vol.
5,57 млн
Volume
6,30 млн
P/E ratio
33,80
52-wk high
16,58 CN¥
52-wk low
8,54 CN¥
EPS
0,28 CN¥
Shares outstanding
950,40 млн
No. of employees
3 мың
News stories
From web sources and news partners
About Pacific Shuanglin Bio-pharmacy Co Ltd
CEO-
Employees2,76 мың
Founded1993
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
631,66 млн
1,01 млрд
342,92 млн
486,92 млн
Cost of goods sold
345,25 млн
674,87 млн
223,50 млн
333,55 млн
Cost of revenue
345,25 млн
674,87 млн
223,50 млн
333,55 млн
Research and development expenses
12,11 млн
25,01 млн
10,34 млн
6,09 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142,84 млн
120,55 млн
83,99 млн
76,71 млн
Operating expense
161,42 млн
162,30 млн
98,57 млн
90,31 млн
Total operating expenses
506,67 млн
837,17 млн
322,07 млн
423,86 млн
Operating income
124,99 млн
177,29 млн
20,85 млн
63,06 млн
Other non operating income
-236,66 м.
-32,79 мың
-2,74 млн
2,22 млн
EBT including unusual items
138,01 млн
93,36 млн
29,08 млн
69,80 млн
EBT excluding unusual items
134,60 млн
178,56 млн
28,71 млн
70,38 млн
Income tax expense
16,43 млн
31,33 млн
6,34 млн
7,56 млн
Effective tax rate
11,90%
33,55%
21,82%
10,83%
Other operating expenses
5,57 млн
7,62 млн
6,17 млн
5,92 млн
Net income
121,39 млн
62,09 млн
22,97 млн
61,33 млн
Net profit margin
19,22%
6,12%
6,70%
12,60%
Earnings per share
-
-
-
-
Interest and investment income
15,61 млн
6,69 млн
15,52 млн
11,30 млн
Interest expense
-5,76 млн
-5,39 млн
-4,92 млн
-6,20 млн
Net interest expenses
9,85 млн
1,29 млн
10,60 млн
5,09 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
155,19 млн
210,35 млн
53,91 млн
100,07 млн
Gain or loss from assets sale
785,80 м.
-756,00 м.
-
135,62 м.
AI content may include mistakes. Learn more
Google қолданбалары